3 min read
Save
Statin use has ‘strong link’ to survival benefits for patients with certain blood cancers
The addition of statin medications to contemporary therapies like ibrutinib could significantly improve survival for patients with certain hematologic malignancies, according to results of a retrospective study.
May 09, 2025
5 min read
Save
Com

Lymphoma News

Commentary
Article
May 12, 2025
Author(s):
Fact checked by:
Ashling Wahner
In Partnership With:
Listen
The FDA accelerated approval of avutometinib in combination with defactinib (Avmapki Fakzynja Co-pack) represents a meaningful therapeutic development for patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), a rare and his

Avutometinib/Defactinib Expands Treatment Options for KRAS-Mutant Low-Grade Serous Ovarian Cancer

Vir Biotechnology, a clinical-stage immunology company, announced results from its MARCH phase 2 trial, which showed the proportion of participants with undetectable hepatitis B surface antigen (HBsAg) at 24 weeks post-end of treatment, was achieved by 17% (3/18) and 21% (3/14) of participants with baseline HBsAg<1,000 IU/mL who were receiving tobe

Vir Biotechnology Announces Results of its Potential Hepatitis B Cure Combination Therapy

S1 Ep161. Highlighting Advancements in Personalized T-Cell Lymphoma Treatment
S1 Ep161. Highlighting Advancements in Personalized T-Cell Lymphoma Treatment
S1 Ep161. Highlighting Advancements in Personalized T-Cell Lymphoma Treatment
Oncology On The Go• SUBSCRIBE
0:00
17:45
In a conversation with CancerNetwork®, Viviana Cortiana, MS4, medical stude

Highlighting Advancements in Personalized T-Cell Lymphoma Treatment

WhiteBlackRedGreenBlueYellowMagentaCyanOpaqueSemi-TransparentBlackWhiteRedGreenBlueYellowMagentaCyanOpaqueSemi-TransparentTransparentBlackWhiteRedGreenBlueYellowMagentaCyanTransparentSemi-TransparentOpaque
50%75%100%125%150%175%200%300%400%NoneRaisedDepressedUniformDropshadowProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace Ser

Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer

Final diagnosis
Ocular syphilis and concurrent neurosyphilis
History of the Present Illness
A 50-year-old man with a medical history notable for HIV/AIDS and a history of previously treated neurosyphilis presented with acute on chronic bilateral visual changes. The patient was in his usual state of health until 6 months prior to admission, when he

Ocular Syphilis and Neurosyphilis in a Patient Living With HIV

Osinusi is vice president, Clinical Research for Hepatitis, Respiratory and Emerging Viruses at Gilead.
Articles
Hepatitis D Patients Maintain Undetectable Virus Nearly 2 Years After Bulevirtide Therapy
John Parkinson;Anu Osinusi, MD
Anu Osinusi, MD provides insights on the findings of Gilead’s investigational therapy from its phase 3 MYR301 study,

Anu Osinusi, MD

Can a virtual nurse persuade people to get vaccinated? Scientists from SWPS University have proven that it is possible. Finding new forms of informing people about vaccinations is particularly important for public health while some question their validity.
While the consensus in the medical and scientific community is that preventive vaccinations a

Study shows a virtual nurse can persuade you to get vaccinated

EP: 1.Optimizing Therapy in HR+/HER2+ Breast Cancer: Balancing Endocrine, HER2-Targeted, and Chemotherapy Options
EP: 2.Treatment Planning for HER2+ Breast Cancer: The Role of Ovarian Function Suppression
EP: 3.HER2+ Breast Cancer Management: Navigating GnRH Agonist Choice and Patient Experience
Now Viewing
EP: 4.Navigating Early-Line Treatment Opt

Navigating Early-Line Treatment Options for HER2+ Metastatic Breast Cancer

In people with relapsing forms of multiple sclerosis (MS) treated with Ocrevus (ocrelizumab), levels of B-cells can help to predict the risk of progression independent of relapse activity, a new study reports.
“Our results unveil a discernible relationship between the degree of B-cell depletion and disease progression in individuals with [relapsing

B-cell levels can predict PIRA risk in relapsing MS patients on Ocrevus

Articles
Communication Between Leadership and Clinicians Improves Cancer Care
Leadership of a new cancer center as part of JFK University Medical Center discuss how they can support frontline clinicians.
Latest Updated Articles
Published: January 24th 2025 | Updated: February 6th 2025
FDA Approves Treosulfan Combo Injection for HSCT Conditioning in

Robert C. Garrett

Although the gut microbiome is vital in host immune system education and thrombotic pathways, its precise role in ITP-associated bleeding risk remains to be elucidated.
Among pediatric patients with immune thrombocytopenia (ITP), distinct bleeding phenotypes have been recognized, which vary according to gut microbiota and immune host factors.
A pro

Microbiota, Immune Host Factors Linked to Bleeding Risk in Pediatric ITP

Within the past 3 years, the BRAF V600E–mutant NSCLC treatment arsenal has seen positive shifts toward improved standards of care [SOC] following the FDA approvals of dabrafenib plus trametinib and encorafenib plus binimetinib, according to Joseph C. Murray, MD, PhD, who added that uncertainty remains regarding optimal treatments following progress

SOC Encorafenib/Binimetinib Sets a Precedent for Therapeutic Improvements in BRAF V600E–Mutant NSCLC

"These findings add to the growing body of evidence supporting revumenib’s paradigm-changing potential as treatment for a significant subset of acute leukemias," according to study author Martha L. Arellano, MD.
Treatment with revumenib produced clinically meaningful responses in an older population of patients with heavily pretreated relapsed/refr

Revumenib Yields Meaningful Benefit in NPM1-Mutated Acute Myeloid Leukemia

SerpinPC treatment of factor VIII-deficient mice fully restored hemostasis in a tail-clip model in a dose- and time-dependent manner.
SerpinPC effectively restored hemostasis in factor VIII-deficient mice, demonstrating a dose- and time-dependent reduction in blood loss in a hemophilia A tail-clip model, according to results from a study published

SerpinPC Restored Hemostasis in Mouse Model of Hemophilia A

Prevalence of smoking continued to drop during pandemic, but prevalence of excess body weight, HPV vaccination remained stable.
(HealthDay News) — Smoking rates continued to decline during the COVID-19 pandemic, but other major risk factors for cancer remained stable, according to a study published online April 23 in Cancer Epidemiology, Biomarkers

Prevalence of Most Cancer Risk Factors Unchanged Before, After Pandemic

SAN DIEGO -- Minor papilla endoscopic sphincterotomy did not reduce the risk of acute pancreatitis in patients with acute recurrent pancreatitis and pancreas divisum, a sham-controlled randomized trial showed.
Among 148 patients, 34.7% of those who underwent endoscopic retrograde cholangiopancreatography (ERCP) with minor papilla sphincterotomy had

Minor Papilla Sphincterotomy Did Not Reduce Risk of Acute Pancreatitis

Contact

Advertise

Other industries

Empower vascular access teams with tools that streamline workflows, enhance teamwork, and improve outcomes.

Tools for Efficient Vascular Access | Salubrity Online

Gebauer’s Pain Ease® works in just 4-10 seconds!

Give patients the comfort they deserve

Ivenix Infusion System

You have several options—but you also have several reasons to choose one above the rest.
Learn more now.


Prescribing IVIg?

AVA Consensus Statement recommend adhesives like gum mastic to secure PIVC dressings and devices.